A Preliminary Cost Analysis of Schizophrenic Patients Stabilized on 1-Monthly Long Acting Paliperidone Palmitate (PP1M) Injection Switching To Paliperidone Palmitate 3-Monthly Formulation (PP3M) In The Public Sector of Hong Kong
Oct 1, 2017, 00:00
10.1016/j.jval.2017.08.1877
https://www.valueinhealthjournal.com/article/S1098-3015(17)32211-8/fulltext
Title :
A Preliminary Cost Analysis of Schizophrenic Patients Stabilized on 1-Monthly Long Acting Paliperidone Palmitate (PP1M) Injection Switching To Paliperidone Palmitate 3-Monthly Formulation (PP3M) In The Public Sector of Hong Kong
Citation :
https://www.valueinhealthjournal.com/action/showCitFormats?pii=S1098-3015(17)32211-8&doi=10.1016/j.jval.2017.08.1877
First page :
A711
Section Title :
Disease-Specific Studies
Open access? :
No
Section Order :
1706